Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Tokyo  >  Astellas Pharma Inc    4503   JP3942400007

ASTELLAS PHARMA INC (4503)
Mes dernières consult.
Most popular
  Report  
SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
Latest news on ASTELLAS PHARMA INC
04/24SHOWA DENKO K K : SDK Provides LED for Research on Rice-Based Oral Vaccine "Muco..
AQ
04/23ASTELLAS PHARMA : Announces Sale of Certain Agensys Research Facilities to Kite,..
AQ
04/21ASTELLAS PHARMA : sells certain U.S. research facilities to Gilead
AQ
04/19ASTELLAS PHARMA : Findings on Immunoglobulins Discussed by Investigators at Aste..
AQ
04/16ACTINIUM PHARMACEUTICALS : to Showcase Capabilities of its AWE Technology Platfo..
AQ
04/12ASTELLAS PHARMA : Named "Outstanding Employer" for Supporting Employees with Mil..
AQ
04/12ASTELLAS PHARMA : New Colitis Data Have Been Reported by Investigators at Astell..
AQ
04/05SEATTLE GENETICS : and Astellas Receive FDA Breakthrough Therapy Designation for..
AQ
04/05ASTELLAS PHARMA : Studies from Astellas Pharma in the Area of Nephropathy Descri..
AQ
04/03ASTELLAS PHARMA : to Participate in 'Neglected Tropical Diseases Drug Discovery ..
AQ
04/02ASTELLAS PHARMA : Announces Personnel Change
AQ
03/30ACTINIUM PHARMACEUTICALS : Announces Collaborative Research Partnership with Ast..
AQ
03/29ASTELLAS PHARMA : Patent Issued for Pharmaceutical Composition Comprising Solife..
AQ
03/29ASTELLAS PHARMA : New Findings in Lymphoma Described from Astellas Pharma phenyl..
AQ
03/29ASTELLAS PHARMA : Investigators from Astellas Pharma Have Reported New Data on C..
AQ
03/29ASTELLAS PHARMA INC. : - Notice of Completion of Acquisition of Own Shares
AQ
03/29ACTINIUM PHARMACEUTICALS : Announces Collaborative Research Partnership with Ast..
AQ
03/28ASTELLAS PHARMA INC. : - SUJANU Combination Tablets combining type-2 diabetes dr..
AQ
03/28ASTELLAS PHARMA INC : Ex-dividend day for for final dividend
FA
03/27ASTELLAS PHARMA : Receives Orphan Drug Designation from the Japanese MHLW for Gi..
AQ
03/27SEATTLE GENETICS : and Astellas Receive FDA Breakthrough Therapy Designation for..
AQ
03/22ASTELLAS PHARMA : Data on Type 2 Diabetes Discussed by Researchers at Astellas P..
AQ
03/22ASTELLAS PHARMA : New Findings on Taxol Therapy from Astellas Pharma Summarized
AQ
03/22PFIZER INC. : - U.S. FDA Grants Priority Review for a Supplemental New Drug Appl..
AQ
03/21ASTELLAS PHARMA INC. : - European Medicines Agency Accepts Type II Variation App..
AQ
03/21PFIZER : & Astellas announce US FDA grants priority review status to sNDA for Xt..
AQ
03/20ASTELLAS PHARMA : Announces Personnel Change
AQ
03/20PFIZER : U.S. FDA Grants Priority Review for a Supplemental New Drug Application..
AQ
03/19MANAGEMENT TRACKS : America's Health Insurance Plans, Astellas
AQ
03/14ASTELLAS PHARMA : Received Approval for Solifenacin Oral Suspension for Pediatri..
AQ
03/09ASTELLAS PHARMA : Tottori University and Astellas Enter into the Global Exclusiv..
AQ
03/07ASTELLAS PHARMA : Announces Status of Acquisition of Own Shares
AQ
03/02BIOCENTURY - MANAGEMENT TRACKS : Alkermes, Helsinn
AQ
03/01ASTELLAS PHARMA : Reports Findings in Drug Delivery Systems (Ion-Responsive Drug..
AQ
02/23ASTELLAS PHARMA : Patent Application Titled "Pharmaceutical Composition Containi..
AQ
02/21ASTELLAS PHARMA : adding `off-the-shelf` stem cell tech in $102.5m acquisition
AQ
02/20ASTELLAS PHARMA : Launches Global Campaign in Collaboration with CNN as Part of ..
AQ
02/16ASTELLAS PHARMA : scoops up Universal Cells for $102.5m
AQ
02/16ASTELLAS PHARMA : Launches Global Campaign in Collaboration with CNN as Part of ..
PU
02/15DISCOVERY COMMUNICATIONS : Astellas Partners with Discovery Communications for i..
AQ
02/14ASTELLAS PHARMA : Acquires Universal Cells, Inc. (pdf 178KB)
PU
02/14ASTELLAS PHARMA : Partners with Discovery Communications for its Global Branding..
PU
02/13CENTRAL NERVOUS SYSTEM DRUGS MARKET : Central Nervous System Drugs Market Overv..
AQ
02/12ASTELLAS PHARMA : Announce Top-Line Results for Two Phase 3 Trials of Peficitini..
AQ
02/09BIOCENTURY - MANAGEMENT TRACKS : Arcturus, Kymera
AQ
02/08ASTELLAS PHARMA : Findings on Pain Reported by Investigators at Astellas Pharma ..
AQ
02/08ASTELLAS PHARMA : to Present New Oncology Data at the 2018 ASCO Genitourinary Ca..
AQ
02/08ASTELLAS PHARMA : Announce Top-Line Results for Two Phase 3 Trials of Peficitini..
PU
02/07ASTELLAS PHARMA : Phase 3 PROSPER trial shows Xtandi reduces risk of metastasis ..
AQ
02/06ASTELLAS PHARMA : CMV DNA Vaccine Candidate Fails to Meet Endpoints in Phase 3 T..
AQ
02/06PFIZER : Phase 3 PROSPER Trial Shows XTANDI (enzalutamide) Significantly Reduced..
AQ
02/05ASTELLAS PHARMA : Announces Acquisition of Own Shares
AQ
02/05ASTELLAS PHARMA : Announces Transition to a Company with an Audit & Supervisory ..
AQ
02/05ASTELLAS PHARMA : Announces Changes in Management Structure, Global Function, an..
PU
02/05ASTELLAS PHARMA : Announces Personnel Changes and Organizational Changes (pdf 30..
PU
02/02ASTELLAS PHARMA : Reports Financial Results for the First Nine Months of FY2017
AQ
02/01ASTELLAS PHARMA : and Vical Announce Top-Line Results for Phase 3 Trial of Cytom..
AQ
01/31ASTELLAS PHARMA : Announces Transition to a Company with an Audit & Supervisory ..
PU
01/31ASTELLAS PHARMA : Announces Acquisition of Own Shares (pdf 119KB)
PU
01/31ASTELLAS PHARMA : Reports Financial Results for the First Nine Months of FY2017 ..
PU
01/31ASTELLAS PHARMA : Reports Financial Results for the First Nine Months of FY2017
BU
01/30ASTELLAS PHARMA : to Present New Oncology Data at the 2018 ASCO Genitourinary Ca..
AQ
01/25ASTELLAS PHARMA : Receives Orphan Designation from the European Commission for G..
AQ
01/24Consortium unveils report to increase antibiotic innovation
AQ
01/24ASTELLAS PHARMA : Completes Acquisition of Mitobridge, Inc. (pdf 242KB)
PU
01/23GILEADS KITE TO BUY EX-AGENSYS R&D S : report
AQ
01/23ASTELLAS PHARMA : Receives Orphan Designation from the European Commission for G..
PU
01/22ASTELLAS PHARMA : and Vical Announce Top-Line Results for Phase 3 Trial of Cytom..
PU
01/19ASTELLAS PHARMA : Research Data from Astellas Pharma Update Understanding of Med..
AQ
01/19ASTELLAS PHARMA : Reports Summarize Central Nervous System Agents Findings from ..
AQ
01/19ASTELLAS PHARMA : New Pelvic Pain Study Findings Have Been Reported by Investiga..
AQ
01/15AMGEN : Astellas Pharma Inc - Repatha SC Injection 420 mg Auto Mini Doser Launch..
AQ
01/12ASTELLAS PHARMA : Submits Supplemental New Drug Application for Approval of Addi..
AQ
01/12ASTELLAS PHARMA : Repatha® SC Injection 420 mg Auto Mini Doser Launched in Japan..
PU
01/11ASTELLAS PHARMA : Researchers from Astellas Pharma Report New Studies and Findin..
AQ
1  2  3  4  5  6  7  8Next
Financials ( JPY)
Sales 2018 1 299 B
EBIT 2018 220 B
Net income 2018 179 B
Finance 2018 338 B
Yield 2018 2,27%
P/E ratio 2018 17,29
P/E ratio 2019 16,32
EV / Sales 2018 2,26x
EV / Sales 2019 2,20x
Capitalization 3 275 B
Chart ASTELLAS PHARMA INC
Duration : Period :
Astellas Pharma Inc Technical Analysis Chart | 4503 | JP3942400007 | 4-Traders
Technical analysis trends ASTELLAS PHARMA INC
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 12
Average target price 1 625  JPY
Spread / Average Target 2,6%
EPS Revisions
Managers
NameTitle
Kenji Yasukawa President, Chief Executive Officer & Director
Yoshihiko Hatanaka Chairman
Chikashi Takeda Chief Financial Officer
Mitsunori Matsuda Senior Executive Officer & President-Technology
Roderick Christmon Executive Director-Medical & Development
Sector and Competitors
1st jan.Capitalization (M$)
ASTELLAS PHARMA INC9.17%30 041
JOHNSON & JOHNSON-9.35%339 783
PFIZER1.13%217 897
NOVARTIS-7.72%204 972
ROCHE HOLDING LTD.-11.72%192 109
MERCK AND COMPANY7.07%158 571